On Nov. 19, Health Canada authorized the Pfizer COVID-19 vaccine for 5- to 11-year-olds. Its decision followed in the footsteps of the U.S. Food and Drug Administration’s emergency use authorization on Oct. 29 for the same age group.
In an exclusive interview with The Defender, Amy Bolin said in order to be approved for a double-lung transplant, her husband had to be fully vaccinated for COVID even though he’d had the virus and recovered. After his second Moderna shot, he developed a pulmonary embolism and heart condition and died before he could get new lungs.
I can tell you with certainty that right now attorneys for newly acquitted defendant Kyle Rittenhouse are working overtime. They are combing through every slanderous statement made about this young man. Every defamatory comment offered up before any facts were presented in a court of law is now under the microscope for possible litigation.
More injuries have been linked to the experimental Covid-19 vaccine in the last 11 months than all other vaccines have been linked to in the prior 30 years.
In an exclusive interview with The Defender, Dr. Paul Marik said patients are dying “unnecessarily and unlawfully” because the hospital where he is director of the ICU prioritizes expensive drugs like Remdesivir while banning more effective and less costly treatments.
Pfizer is suing one of its employees after she allegedly stole thousands of the company’s files with the intent to take a job with one of its competitors, with some of the files including information about the Covid-19 vaccine.
In an analysis presented during a meeting of the American Heart Association, Dr. Steven Gundry, a pioneer in infant heart transplant surgery, said mRNA COVID vaccines put many patients at higher risk of a new acute coronary syndrome, such as a heart attack.
In a November 12, 2021, blog post, Maryanne Demasi, Ph.D., reviews how the benets of the COVID-19 shots have been exaggerated by the drug companies and misrepresented to the public by an uncritical media. She has previously given many lectures on how the drug companies conated absolute and relative risks for statin drugs.